Soft mist delivery platform for targeted airway drug delivery

Overview

Resyca BV presents an innovative soft mist delivery platform designed for precise and targeted drug delivery to both the upper and lower airways. This proprietary aerosol technology offers the unique capability of creating precise particle size distributions, ensuring that therapeutic molecules reach their intended targets in the respiratory system. By optimizing molecule delivery, this platform enhances the efficacy of treatments, making it suitable for a range of applications from nasal sprays to lung therapies.

Technical specifications

Key features:

• Proprietary technology for precise particle size distribution
• Capable of targeting both upper airway (nasal) and lower airway (lung) delivery
• Adaptable platform for various molecules and drugs
• Designed for scalability to meet over-the-counter (OTC) product demands

Applications:

• Soft mist nasal sprays for upper airway conditions
• Inhalation therapies for lower airway and lung conditions

Technology readiness level

This platform has achieved a Technology Readiness Level of 9, indicating that it is fully developed and ready for commercial deployment. Resyca BV offers comprehensive services, from feasibility studies to clinical and commercial manufacturing, ensuring a smooth transition from development to market-ready products.